Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2014

View Archived Issues

BIND Therapeutics partners with Roche on targeted nanopharmaceuticals

Vernalis and Servier Bcl-2 inhibitor enters phase I

German group synthesizes novel protein kinase inhibitors for cancer

New agents for hepatitis C virus presented by HEC Pharm

ChemoCentryx designs new chemokine receptor ligands

Enanta Pharmaceuticals designs new cyclosporin analogues for HCV and HIV infection

German researchers patent novel agents for pain and other disorders

Researchers at Roche design novel Hdm2 inhibitors for cancer

Antibe Therapeutics receives Canadian clearance to begin phase I program for ATB-346

Kadmon advances study of KD-020 in autosomal dominant polycystic kidney disease

Navitor Pharmaceuticals established to identify mTORC1 pathway drugs

Updated phase I/II data on AP-26113 in NSCLC reported

Novel candidate PET ligands for central histamine H3 receptors

Sanofi to return rights to MM-121 to Merrimack

Alnylam and the Alpha-1 Project form collaboration for ALN-AAT

GlycoMimetics begins phase I trial of GMI-1271 as a potential drug for blood-related cancers

Apitope begins preclinical Graves' disease program

International Stem Cell completes study in Parkinson's disease program

Molecular probe developed for optical imaging of Bcl-2 expression during chemotherapy

Mesenchymal stromal cell therapy evaluated in idiopathic osteonecrosis of femoral head

Safety and efficacy of autologous progenitor cells in pediatric hypoplastic left heart syndrome

Enrollment completed in phase II studies of VB-201 in psoriasis and ulcerative colitis

SillaJen changes name following acquisition of Jennerex

Arrowhead unveils RNAi candidate for alpha-1-antitrypsin-associated liver disease

FDA approves oral and intravenous tedizolid phosphate for bacterial skin infections

Japanese approval of Prevenar 13 expanded to include elderly people

Mirena 52 mg approved for additional indication in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.